Jun 2026 (Q1 FY27) — Aug 13, 2026
Beyond Air Q1 FY27 — Strengthening Foundation for Gen 2 LungFit PH Launch
Read the full callBeyond Air (XAIR) earnings
- Jun 2026
- Jun 2026 (Q1 FY27)
- Mar 2026
Beyond Air earnings: last reported Thu, 13 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 1.8 | +0.5% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | -374.0 | +58.8 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | -7.9 | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. The year-earlier figure was zero or a loss, so no percentage is shown. |
Price
$2.13 −1.39% · −$0.03
Performance −95.5% 1Y
1Y: $47.2 on 17 Oct 2025 → $2.13. High $48.8 (20 Oct 2025), low $2.1 (14 Oct 2026).
- Previous close
- $2.16
- 52-week range
- $2.1 – $48.8
- One year
- −95.64%
Overview
- Symbol
- XAIR
- Sector
- Health Care
- Exchange
- US
- Currency
- USD
Call summaries
Mar 2026 (Q4 FY26) — Jun 26, 2026
Beyond Air Q4 FY26 — Revenue more than doubles to $7.7M as company debuts calendar-year guidance ahead of Gen 2 LungFit PH FDA decision
Read the full callEvery analysed call
Beyond Air earnings calls (XAIR)
Financials
What the filings say
Net profit, year on year: −3% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 |
| Operating profit | -13 | -11 | -7 | -8 | -8 | -7 | -7 | -7 |
| Operating margin | −1608.2% | −1021.6% | −622.6% | −432.8% | −421.4% | −300.6% | −376.0% | −374.0% |
| Other income | -1 | -2 | -1 | -0 | -1 | -1 | -3 | -2 |
| Interest | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | -14 | -13 | -8 | -8 | -8 | -8 | -10 | -8 |
| Net profit | -13 | -13 | -8 | -8 | -8 | -7 | -10 | -8 |
| EPS ($ per share) | -5.67 | -2.96 | — | -30.67 | -1.25 | -0.85 | — | -11 |
| Line item | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reserves | -38 | -58 | -80 | -124 | -179 | -240 | -286 | -320 |
| Total liabilities | 5 | 9 | 10 | 21 | 27 | 30 | 16 | 29 |
| Fixed assets | 0 | 0 | 1 | 2 | 5 | 9 | 11 | 8 |
| Investments | 7 | — | — | — | 17 | 23 | 2 | 5 |
| Total assets | 9 | 27 | 41 | 99 | 69 | 57 | 30 | 35 |
| Line item | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 1 | -15 | -20 | -23 | -33 | -56 | -38 | -18 |
| Cash from investing | -2 | 4 | -1 | -1 | -21 | -12 | 15 | -4 |
| Cash from financing | 1 | 35 | 30 | 79 | 3 | 43 | 17 | 29 |
| Net cash flow | 1 | 24 | 10 | 55 | -51 | -25 | -7 | 7 |
| Capital expenditure | -0 | -0 | -1 | -1 | -4 | -6 | -6 | -1 |
| Free cash flow | 1 | -15 | -21 | -25 | -37 | -62 | -44 | -19 |
Insider filings
6 filings between Jul 29, 2026 and Oct 13, 2026.
Open market
decisions to buy or sellPurchases
$287.3K
6 purchases by 3 insiders
Sales
None
No insider sold shares.
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Goodman Robert Scott | $200.0K | — | Jul 29, 2026 |
| Lin Yi-Chien | $62.4K | — | Oct 13, 2026 |
| MOORHEAD DANIEL J | $25.0K | — | Jul 29, 2026 |
Latest filings (12)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Oct 13, 2026 | Lin Yi-Chien 10% owner | Purchase | 2,607 | $5.8K |
| Oct 1, 2026 | Lin Yi-Chien 10% owner | Purchase | 15,393 | $43.1K |
| Sep 30, 2026 | Lin Yi-Chien 10% owner | Purchase | 2,000 | $5.4K |
| Sep 29, 2026 | Lin Yi-Chien 10% owner | Purchase | 3,000 | $8.1K |
| Jul 29, 2026 | MOORHEAD DANIEL J Chief Financial Officer | Purchase | 4,340 | $25.0K |
| Jul 29, 2026 | Goodman Robert Scott Chief Executive Officer | Purchase | 34,722 | $200.0K |
| Jul 21, 2025 | Lisi Steven A. CEO and Chairman of the Board | Purchase | 6,000 | $19.5K |
| Mar 14, 2025 | Carey Robert Director | Purchase | 10,000 | $2.5K |
| Mar 14, 2025 | Carey Robert Director | Purchase | 990,000 | $247.5K |
| Feb 19, 2025 | Gaul Michael A. Chief Operating Officer | Purchase | 6,000 | $2.3K |
| Sep 26, 2024 | Lisi Steven A. CEO and Chairman of the Board | Purchase | 1,476,626 | $744.7K |
| Sep 26, 2024 | Carey Robert Director | Purchase | 1,476,626 | $744.7K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for Beyond Air, Inc.
Free account. Everything above stays public.
Write why you follow Beyond Air, Inc. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading